Total Payments
$818,244
2024 Payments
$31,747
Companies
56
Transactions
1,918
Medicare Patients
4,408
Medicare Billing
$657,759
Payment Breakdown by Category
Other$660,691 (80.7%)
Travel$107,541 (13.1%)
Food & Beverage$32,190 (3.9%)
Consulting$17,650 (2.2%)
Education$173.19 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $656,641 | 326 | 80.2% |
| Travel and Lodging | $107,541 | 323 | 13.1% |
| Food and Beverage | $32,190 | 1,243 | 3.9% |
| Consulting Fee | $17,650 | 11 | 2.2% |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $2,250 | 1 | 0.3% |
| Honoraria | $1,800 | 1 | 0.2% |
| Education | $173.19 | 13 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $275,904 | 453 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $156,377 | 197 | $0 (2021) |
| Lilly USA, LLC | $132,225 | 318 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $79,281 | 113 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $64,283 | 121 | $0 (2020) |
| Mannkind Corporation | $39,719 | 168 | $0 (2024) |
| ABBVIE INC. | $36,957 | 70 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $12,219 | 48 | $0 (2024) |
| IBSA Pharma Inc. | $3,355 | 18 | $0 (2024) |
| Amgen Inc. | $2,690 | 88 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $31,747 | 152 | Lilly USA, LLC ($16,664) |
| 2023 | $43,993 | 149 | Lilly USA, LLC ($24,918) |
| 2022 | $101,801 | 254 | Lilly USA, LLC ($56,383) |
| 2021 | $67,683 | 231 | Novo Nordisk Inc ($49,521) |
| 2020 | $46,172 | 185 | Novo Nordisk Inc ($14,705) |
| 2019 | $138,553 | 271 | Novo Nordisk Inc ($49,018) |
| 2018 | $191,554 | 341 | Merck Sharp & Dohme Corporation ($62,759) |
| 2017 | $196,741 | 335 | Novo Nordisk Inc ($47,734) |
All Payment Transactions
1,918 individual payment records from CMS Open Payments — Page 1 of 77
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/17/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Endocrinology | ||||||
| 12/16/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: Endocrinology | ||||||
| 12/12/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: DIABETES MEDICINE | ||||||
| 12/06/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Endocrinology | ||||||
| 12/04/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/25/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Endocrinology | ||||||
| 11/21/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $123.88 | General |
| Category: Endocrinology | ||||||
| 11/14/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $109.01 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/05/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/05/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $7.88 | General |
| Category: Endocrinology | ||||||
| 10/23/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/21/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Durable Pump | ||||||
| 10/18/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/17/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $21.42 | General |
| Category: Endocrinology | ||||||
| 10/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Obesity | ||||||
| 10/14/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $10.24 | General |
| Category: Bone Health | ||||||
| 09/30/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/26/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $113.28 | General |
| Category: Endocrinology | ||||||
| 09/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 1,032 | 1,930 | $483,250 | $152,872 |
| 2022 | 8 | 1,074 | 2,140 | $527,615 | $167,600 |
| 2021 | 9 | 1,169 | 2,304 | $569,493 | $188,307 |
| 2020 | 9 | 1,133 | 2,009 | $523,648 | $148,981 |
Total Patients
4,408
Total Services
8,383
Medicare Billing
$657,759
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 518 | 1,157 | $298,737 | $98,523 | 33.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 136 | 177 | $61,318 | $23,321 | 38.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 94 | 94 | $46,666 | $14,549 | 31.2% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 132 | 318 | $37,063 | $7,673 | 20.7% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 77 | 81 | $23,656 | $6,312 | 26.7% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 56 | 56 | $12,953 | $2,001 | 15.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 47 | $2,857 | $492.66 | 17.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 597 | 1,408 | $363,546 | $121,488 | 33.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 106 | 121 | $41,918 | $15,387 | 36.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 85 | 85 | $42,198 | $13,100 | 31.0% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 124 | 335 | $39,044 | $8,471 | 21.7% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 77 | 79 | $23,072 | $6,265 | 27.2% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 56 | 56 | $12,953 | $2,011 | 15.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 13 | $2,270 | $458.61 | 20.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 17 | 43 | $2,614 | $418.84 | 16.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 601 | 1,486 | $383,685 | $133,350 | 34.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 112 | 126 | $43,650 | $16,508 | 37.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 105 | 105 | $52,127 | $16,122 | 30.9% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 115 | 313 | $36,480 | $8,057 | 22.1% |
| 76536 | Ultrasound of head and neck | Office | 2021 | 76 | 82 | $23,948 | $6,946 | 29.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 60 | 66 | $11,527 | $4,428 | 38.4% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 63 | 63 | $14,572 | $2,322 | 15.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 25 | 51 | $3,100 | $465.77 | 15.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2021 | 12 | 12 | $403.20 | $108.24 | 26.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 572 | 1,287 | $332,749 | $96,139 | 28.9% |
About Dr. Denis Becker, MD
Dr. Denis Becker, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750359113.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Denis Becker, MD has received a total of $818,244 in payments from pharmaceutical and medical device companies, with $31,747 received in 2024. These payments were reported across 1,918 transactions from 56 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($656,641).
As a Medicare-enrolled provider, Becker has provided services to 4,408 Medicare beneficiaries, totaling 8,383 services with total Medicare billing of $657,759. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Raleigh, NC
- Active Since 03/10/2006
- Last Updated 09/13/2011
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1750359113
Products in Payments
- Ozempic (Drug) $94,851
- STEGLATRO (Drug) $94,743
- MOUNJARO (Drug) $85,425
- INVOKANA (Drug) $64,260
- Tresiba (Drug) $60,075
- JANUVIA (Drug) $50,131
- RYBELSUS (Drug) $41,240
- AFREZZA (Drug) $39,719
- Rybelsus (Drug) $37,650
- SOLIQUA (Drug) $29,449
- TOUJEO (Drug) $29,147
- Victoza (Drug) $20,645
- Androgel (Drug) $20,621
- BASAGLAR (Drug) $17,675
- JARDIANCE (Drug) $16,349
- SOLIQUA 100/33 (Drug) $13,896
- BAQSIMI (Drug) $8,434
- SYNTHROID (Drug) $7,555
- TOUJEO (Biological) $6,578
- Xultophy 100/3.6 (Drug) $6,126
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Raleigh
Corey Berlin, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $1.1M
Endocrinology, Diabetes & Metabolism $1.1M
Dr. Elizabeth Holt, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $496,206
Endocrinology, Diabetes & Metabolism $496,206
Mrs. Bhakti Paul, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $447,225
Endocrinology, Diabetes & Metabolism $447,225
Anthony Azzi, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $143,111
Endocrinology, Diabetes & Metabolism $143,111
Dr. Julia Warren-Ulanch, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $33,095
Endocrinology, Diabetes & Metabolism $33,095
Glenn Stall, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $8,940
Endocrinology, Diabetes & Metabolism $8,940